Compare KYIV & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KYIV | TVTX |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | N/A | N/A |
| Metric | KYIV | TVTX |
|---|---|---|
| Price | $12.22 | $29.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $37.21 |
| AVG Volume (30 Days) | N/A | ★ 3.2M |
| Earning Date | N/A | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $435,826,000.00 |
| Revenue This Year | N/A | $120.02 |
| Revenue Next Year | N/A | $37.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 114.22 |
| 52 Week Low | N/A | $12.91 |
| 52 Week High | N/A | $42.13 |
| Indicator | KYIV | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.65 |
| Support Level | N/A | $26.78 |
| Resistance Level | N/A | $29.31 |
| Average True Range (ATR) | 0.00 | 2.37 |
| MACD | 0.00 | -0.62 |
| Stochastic Oscillator | 0.00 | 39.37 |
Kyivstar Group Ltd is engaged in mobile communication.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.